Anti-MYL9 Neutralizing Antibody (V3S-0522-YC1813) (CAT#: V3S-0522-YC1813)

Send Inquiry
  • fig1






Description This product is a monoclonal antibody derived from Human (Homo sapiens), which can specifically recognize Myosin Light Chain 9. The antibody is expressed with mammalian cell transient expression system, serum-free and purified by affinity chromatography. The purity and integrity are tested via SDS-PAGE and SEC-HPLC analysis. Given an antigen, additional QC measures are also desired such as affinity testing and binding validation.
Specifically, the antibody is provided in multiple formats for in vivo and in vitro assays. The Invivo version features greater than 95% purity, ultra-low endotoxin levels (<1 EU/mg or 0.1 EU/mg), and is preservative, stabilizer, and carrier protein-free.
Clonality Monoclonal
Host Species Human
Target Species Human, Mouse
Immunogen Mouse / human Myl9 peptide -KLH
Isotype IgG2, κ


Expression Species HEK293F or CHO
Conjugation None
Purity >95%, determined by SDS-PAGE and/or SEC-HPLC
Endotoxin <1 EU/mg, determined by LAL method
Purification Protein A affinity purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4⁰C within a week. For longer storage, aliquot and store at -20⁰C.


Application ELISA; Inhib; FuncS
Application Notes The antibody is recommended for detection of MYL9 by ELISA, Inhib, FuncS assays.


ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol


Target MYL9
Alternative Name Myosin Light Chain 9; Myosin Regulatory Light Chain 2, Smooth Muscle Isoform; Myosin, Light Polypeptide 9, Regulatory; Myosin Regulatory Light Chain MRLC1; Myosin, Light Chain 9, Regulatory; Myosin Regulatory Light Chain 1; Myosin Regulatory Light Chain 9; 20 KDa Myosin Light Chain;
Gene ID 10398
UniProt P24844
Research Area Signal Pathway; Stem Cell
For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
Online Inquiry